Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto(ETH Zurich), Shyamala Maheswaran(Massachusetts General Hospital), David T. Miyamoto(Broad Institute), David T. Ting(Massachusetts General Hospital), Ravi Kapur(Harvard University), Aditya Bardia(UCLA Health), Amanda Engstrom(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Min Yu(Howard Hughes Medical Institute), Maria Donaldson Collier(The Netherlands Cancer Institute), Brian W. Brannigan(Harvard University), Charles P. Lin(Harvard University), Joel A. Spencer(Massachusetts General Hospital), Ben S. Wittner(Broad Institute), Shannon L. Stott(Shriners Hospitals for Children - Erie), Mehmet Toner(Center for Cancer Research), Huili Zhu(Yantai University), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), Adam Pely(Massachusetts General Hospital)
Cited by 2,477
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k